NANO Nuclear Energy has flipped the script in five sessions: the stock that bears were piling into last week just surged 30%, forcing the borrow market back to maximum stress and leaving short sellers caught in a sharp reversal.
The short-squeeze dynamic is now fully visible in the data. Short interest eased slightly — down just over 1% on Tuesday to 21.0% of the free float — but that modest retreat follows a week in which shares short climbed 8% as the stock simultaneously rallied hard. Bears who built positions at lower levels are now sitting on losses, yet the overall short base remains substantial. Availability has collapsed to just 3.2%, meaning roughly one share is left available to borrow for every thirty-one already lent out. That is the tightest the lending pool has been all year, and it has been stuck below 5% for the past four consecutive sessions. The cost to borrow tells a slightly different story: it has actually eased over the past month, dropping from nearly 6% in late April to 3.8% now. Despite the borrow market running near-dry, lenders haven't yet repriced aggressively — the same divergence flagged in the May 22 convergence note remains in place and has grown more conspicuous as the stock ripped higher.
Options positioning is notably less alarmed than the lending market. The put/call ratio has dropped to 0.44, fractionally below its 20-day average of 0.45, and the z-score of -0.50 is essentially flat. That's a sharp reversal from the 3.5 standard deviation bearish reading on May 22. Call volume is dominating — consistent with the momentum trade chasing the rally — but the PCR hasn't reached the kind of extreme bullish reading that would signal froth. It's a measured response to the price action, not euphoria.
The Street provides thin but directionally consistent cover for bulls. The analyst consensus is Buy, with a mean price target of $47.50 against a current price of $29.07 — implying roughly 63% upside on the Street's models. Note that the most recent analyst actions on record are from August 2025, so these targets should be treated with caution as reflections of current sentiment. The fundamental picture remains pre-revenue: the P/E and EV/EBITDA multiples are both deeply negative, the ORTEX short score of 75.2 places NNE in approximately the 2nd percentile of all stocks by that metric, and EPS momentum ranks in the bottom quartile. The bull case rests entirely on the small modular reactor narrative and option value, not current financials.
Institutional ownership adds an interesting wrinkle. I Financial Ventures Group holds 16.75% of shares — the dominant position — but trimmed 388,000 shares in February. CEO James Walker sold over $1.1 million of stock in late January, and the 10% owner I Financial offloaded a further $9.9 million across the same sessions. That insider selling occurred near current price levels, around $31–35. The net insider activity over the 90-day window ending early March shows net selling of roughly $56 million in value. On the institutional side, Mirae Asset added over 1 million shares through May 1, a notable accumulation that partially offsets the insider outflows.
Peers have broadly rallied in sympathy. SMR gained 16.6% on the week, SES rose 20.2%, and ENVX added 22.3%. The nuclear and clean-energy peer group appears to be catching a broader thematic bid. WWR was the lone laggard, down 2.7% — underscoring that this week's move has sector tailwinds, not just NNE-specific dynamics.
The next earnings event is scheduled for August 13. Between now and then, the key variable to watch is whether availability remains near zero as the stock holds its gains — a sustained squeeze at these levels with no borrow relief and a still-elevated short base is the setup that historically produces the most volatile outcomes.
See the live data behind this article on ORTEX.
Open NNE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
